LICENSE AGREEMENT originally dated as of September 23, 1997 amended and restated in its entirety as of February 22, 2002 by and between ALLIANCE PHARMACEUTICAL CORP. and SCHERING AKTIENGESELLSCHAFTLicense Agreement • November 15th, 2004 • Imcor Pharmaceutical Co • Pharmaceutical preparations • New York
LICENSE AGREEMENT (the "AGREEMENT") originally dated as of September 23, 1997 (the "EFFECTIVE DATE"), and amended and restated in its entirety as of February 22, 2002 (the "RESTATEMENT DATE") by and between ALLIANCE PHARMACEUTICAL CORP., a New York corporation having its principal place of business at 3040 Science Park Road, San Diego, California 92121 (hereinafter referred to as "ALLIANCE") and SCHERING AKTIENGESELLSCHAFT, a German corporation having its principal place of business at 13342 Berlin, Germany (hereinafter referred to as "SCHERING"). Alliance and Schering are sometimes referred to herein individually as a "Party" and collectively as the "Parties."
SETTLEMENT & WORLDWIDE LICENSE AGREEMENTAgreement • November 15th, 2004 • Imcor Pharmaceutical Co • Pharmaceutical preparations • New York
AGREEMENT (“Agreement”) made as of January 31, 2001, (the “Effective Date”), by and among Bracco International B.V. (“Bracco”), a Netherlands corporation having a place of business at 3051 Strawinskylaan, 1077 ZX Amsterdam, Netherlands; Schering Aktiengesellschaft (“Schering”), a German corporation having a place of business at Mullerstrasse 178, 13342 Berlin-Wedding, Germany; and Alliance Pharmaceutical Corp. (“Alliance”), a New York corporation having a place of business at 3040 Science Park Road, San Diego, California 92121. Bracco, Schering, and Alliance may be referred to separately as a “Party” or collectively as the “Parties”.
